HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics
The clinics are located in favorable locations, are revenue generating and EBITDA positive Clinics offer a comprehensive range of mental health services Acquisition is expected to be immediately accretive to revenue and EBITDA for HOPE and NRx MIAMI, Oct. 30, 2024 /PRNewswire/ — HOPE Therapeut
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
Wholly owned first-in-class program anticipated to enter clinical trials in first half of 2025 THOUSAND OAKS, Calif., Oct. 30, 2024 /PRNewswire/ — Capsida Biotherapeutics (“Capsida”) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (OD
TXN Systems Raises SEK 25 Million Series A to Advance First-in-Class Antibiotic
EbsArgent targets urinary tract infections, with early indications of efficacy against many species of multidrug-resistant bacteria STOCKHOLM, Oct. 30, 2024 /PRNewswire/ — Thioredoxin Systems AB (TXN Systems), a pharmaceutical company developing a first-in-class antibiotic for multidrug-resist
AbbVie Reports Third-Quarter 2024 Financial Results
Reports Third-Quarter Diluted EPS of $0.88 on a GAAP Basis, a Decrease of 12.0 Percent; Adjusted Diluted EPS of $3.00, an Increase of 1.7 Percent; These Results Include an Unfavorable Impact of $0.04 Per Share Related to Acquired IPR&D and Milestones Expense Delivers Third-Quarter Net Revenues
Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
MELBOURNE, Australia, Oct. 30, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powered positron emission tomography (PET) imaging with T
FCCN Spectral Capital Welcomes Derrick Youngblood to Advisory Board Strengthening Global Sales Strategy for Vogon Decentralized Cloud Platform
SEATTLE, Oct. 30, 2024 /PRNewswire/ — FCCN Spectral Capital (OTCQB: FCCN), a leading innovator in decentralized cloud technology and advanced quantum ledger solutions, is excited to announce the appointment of Derrick Youngblood to its Advisory Board. With over 20 years of expertise in sales l
CCI Announces Major Expansion Across Geographies and Expertise
Global expansion to Africa, Japan, and a partnership for global standards. Proof of Stake Alliance now part of the CCI ecosystem; new subject matter expert joins. New research partnership with Decentralization Research Center. Read more from CEO Sheila Warren. WASHINGTON, Oct. 30, 2024 /PRNewswire/
Klarna and Worldpay expand partnership to unlock global merchant network
Worldpay, one of the world’s biggest Payment Service Providers (PSPs), strengthens Klarna partnership as digital wallets are expected to grow 15% a year to 2027. Klarna to be offered as a default payment method by Worldpay to their merchants globally, as it expands processing relationship wi
HARRY POTTER: VISIONS OF MAGIC TO OPEN IN SINGAPORE 22 NOVEMBER 2024 AT RESORTS WORLD SENTOSA
EXCLUSIVE PRE-SALE TICKET OPPORTUNITY 5-7 NOVEMBER 2024 TICKETS OPEN TO GENERAL PUBLIC STARTING 8 NOVEMBER 2024 SINGAPORE, Oct. 30, 2024 /PRNewswire/ — Warner Bros. Discovery Global Experiences and NEON, officially announced 22 November as the Opening date for the Asia premiere of Harry Potter
JinkoSolar Announces Third Quarter 2024 Financial Results
SHANGRAO, China, Oct. 30, 2024 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced its unaudited financial results for the third quarter
